H.C. Wainwright Maintains Buy on TRACON Pharmaceuticals, Raises Price Target to $18

H.C. Wainwright maintains TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and raises the price target from $15 to $18.

Benzinga · 12/23/2019 12:55

H.C. Wainwright maintains TRACON Pharmaceuticals (NASDAQ:TCON) with a Buy and raises the price target from $15 to $18.